Group 1 - ID-Sparinvest, a branch of Sparinvest S.A. in Luxembourg, announced that the reporting of net asset values to Nasdaq Copenhagen was missed due to technical challenges [1] - Trading of affected departments is temporarily suspended as a result of the reporting issue [1] - The affected departments include various funds such as Korte Obligationer KL A, Mellemlange Obligationer KL A, Lange Obligationer KL A, and several others, totaling over 30 funds listed [1]

Core Viewpoint - Nykredit Portefølje Administration A/S has requested a suspension of a specific fund due to technical challenges preventing the accurate determination of its net asset value [1] Group 1: Fund Suspension Details - The suspension will be lifted once it is possible to provide a correct net asset value [1] - The affected fund is "Danske Fokusaktier" with ISIN DK0060231777 and Order Book Code NYKDFA [1] Group 2: Contact Information - Any inquiries regarding this announcement can be directed to npa.pm@nykredit or Christian Rye Holm at CRH@nykredit [1]

Core Insights - Nxera Pharma has announced positive top-line results from a Phase 3 study of daridorexant 50 mg for treating insomnia in South Korea, with plans to submit a marketing authorization application in Q1 2026 and expected approval in Q1 2027 [1][7] Company Overview - Nxera Pharma is a biopharma company focused on developing specialty medicines for unmet needs, operating in Japan and globally, and listed on the Tokyo Stock Exchange [12] - The company has established a commercial presence in Japan and is advancing an extensive pipeline through its unique drug discovery platform [12] Product Information - Daridorexant is a dual orexin receptor antagonist approved in Japan as QUVIVIQ® and is marketed in various regions including the US, Canada, and Europe [2][7] - The Phase 3 trial demonstrated significant improvements in subjective total sleep time, sleep onset latency, and wake after sleep onset compared to placebo, with p-values less than 0.0001 [5][7] Market Context - Insomnia affects approximately 15-25% of the adult population in South Korea, translating to about 6.5-11 million individuals, with a notable increase in chronic insomnia patients from 597,529 in 2018 to 722,440 in 2022 [3][10] - The condition is particularly prevalent among women and older adults, with 50% of treated patients aged 60 or above [10] Clinical Study Details - The Phase 3 trial was a multicenter, randomized, double-blind, placebo-controlled study involving adult and elderly patients, with participants receiving either daridorexant 50 mg or placebo for 28 days [4][5] - The incidence of treatment-emergent adverse events was similar between the daridorexant and placebo groups, reported at 13.41% and 14.81% respectively [5]

Core Viewpoint - Danske Bank is executing a share buy-back program totaling DKK 5 billion, aimed at repurchasing up to 45 million shares, which is set to conclude by January 30, 2026 [1][2]. Group 1: Share Buy-Back Program Details - The share buy-back program was announced on February 7, 2025, and is in compliance with the Market Abuse Regulation and Safe Harbour Rules [2]. - As of the last announcement, Danske Bank has accumulated 18,155,560 shares, with a volume-weighted average price (VWAP) of DKK 257.3681, totaling a gross value of DKK 4,672,661,607 [3]. - In week 3 of the program, a total of 324,469 shares were repurchased at an average price of DKK 320.2838, amounting to a gross value of DKK 103,922,150 [4]. Group 2: Cumulative Transactions - The total number of shares repurchased during the entire buy-back program has reached 18,480,029, with an average price of DKK 258.4727, resulting in a total gross value of DKK 4,776,583,757 [4]. - The shares repurchased represent approximately 2.213% of Danske Bank's total share capital [4].

Core Insights - Schneider Electric emphasizes the integration of AI and energy, stating that they are essential for reshaping businesses and driving efficiency and sustainability across various sectors [2] Group 1: Participation in World Economic Forum - Schneider Electric is participating in the World Economic Forum Annual Meeting in Davos, led by CEO Olivier Blum, to promote collaboration in advancing energy technology [1] - The company plans to make several announcements during the meeting, focusing on energy efficiency and technology [2] Group 2: Recognition and Awards - Schneider Electric has been recognized in the MINDS program for its impactful AI applications, with CEO Olivier Blum set to accept awards for EcoStruxure Microgrid Advisor and Snaplogic Touchscreen Room Controller [3] - The company's Wuhan factory received its ninth Lighthouse award from the Global Lighthouse Network for its innovative workforce model, recognized for bridging the skills gap in manufacturing [4] Group 3: Industry Collaboration - Frédéric Godemel, EVP of Energy Management, will lead a meeting of global decision-makers as part of the Bloomberg New Economy Energy Technology Coalition to enhance energy efficiency amid rising electricity demand [5] Group 4: Social Impact Initiatives - Schneider Electric and EDP have launched EDGE Transition, a global accelerator aimed at empowering social entrepreneurs to provide clean energy solutions in underserved communities [6] - The initiative will support early-stage ventures with mentorship and access to capital, promoting equitable energy access and accelerating the energy transition [7]

Core Viewpoint - Bang & Olufsen has initiated a share buyback programme to hedge its share-based long-term incentive programmes, which can now be discontinued based on the assessment of current coverage [1]. Group 1: Share Buyback Programme - The share buyback programme is executed in compliance with EU regulations, specifically the EU Commission Regulation No. 596/2014 and the Safe Harbour Regulation [2]. - The company reserves the right to discontinue the share buyback programme at any time under the Safe Harbour Regulation [2]. Group 2: Transaction Information - Details regarding daily transactions and the total number of shares bought back during the programme will be disclosed in a separate announcement [3].

Core Viewpoint - Festi has executed a buyback program, purchasing a total of 197,000 own shares for 67,066,500 ISK in week 3 of 2026, increasing its total shareholding to 3,972,000 shares, or 1.27% of issued shares [1][3]. Group 1: Buyback Program Details - The buyback program is in accordance with relevant regulations, including the Act on Public Limited Companies and the Regulation of the European Parliament on market abuse [2]. - Prior to the recent purchases, Festi held 3,775,000 own shares, representing 1.21% of issued shares [3]. - The total buyback program aims to repurchase 2,500,000 own shares, or 0.80% of issued shares, with a maximum purchase price cap of 825 million ISK [3]. Group 2: Financial Summary of Purchases - The breakdown of shares purchased during week 3 includes 35,000 shares at a price of 11,760,000 ISK, 46,500 shares at 15,577,500 ISK, 25,500 shares at 8,619,000 ISK, 30,000 shares at 10,170,000 ISK, and 60,000 shares at 20,940,000 ISK [1]. - The total amount spent on the buyback program so far is 403,461,920 ISK [3].

Core Viewpoint - Hermès International regularly publishes the total number of voting rights and shares comprising its share capital, in compliance with French regulations, ensuring transparency for shareholders and the market [2]. Group 1: Share Capital and Voting Rights - As of December 31, 2025, Hermès has a total of 105 million shares, with 569,412 shares comprising the share capital [3]. - The total number of theoretical voting rights, including treasury stock, is 250,591 as of December 31, 2025 [3]. - The effective voting rights exercisable at shareholders' meetings amount to 178,517,494 as of December 31, 2025 [3]. Group 2: Historical Data - The total number of theoretical voting rights has shown fluctuations over the months, with a peak of 638,491 in September 2022 [4]. - The effective voting rights have also varied, with a notable count of 758,072 as of December 31, 2021 [4]. - The data indicates a general trend of increasing effective voting rights from early 2022 to late 2025, reflecting potential growth in shareholder engagement [4].

Core Insights - Nykredit Realkredit A/S has published prepayment data as of January 16, 2026, in compliance with the Danish Capital Markets Act [1] - The prepayment data will be distributed through Nasdaq Copenhagen and is also available in Excel format by ISIN code on Nykredit's investor relations website [1][2] Data Availability - The prepayment data includes information on Nykredit and Totalkredit bonds [1] - For further inquiries regarding the data format and contents, stakeholders can contact Morten Bækmand Nielsen, Head of Investor Relations [2]

Eimskip's Financial Calendar has been altered and the publication of Q3 results moved to 10 November 2025.Other dates remain the same. Management financial results for 2025 28. January 2026Fourth quarter 2025, Financial results for 2025 and sustainability statement3 March 2026Annual General Meeting 202626 March 2026First quarter 2026 5 May 2026Second quarter 2026 25 August 2026Third quarter 2026 10 November 2026Management financial results for 2026 2 February 2027Fourth quarter 2026, Financial results for ...